Skip to content
Thursday, November 19, 2026
Explore the latest in technology, software reviews, and dig…

Zimbabwe Turns Down ‘Lopsided’ American Health Aid Package Due to Data Concerns

Health funding illustration
The proposed US financial assistance would have supported programmes for treating and preventing HIV/Aids, tuberculosis, and malarial diseases.

Zimbabwe has rejected a major US health deal worth $367m (£272m) spanning five years due to the United States' insistence on confidential information.

This move came to light following a government memo from December was leaked, indicating that President Emmerson Mnangagwa believed the arrangement was "unbalanced".

A government representative has since explained that the United States was seeking health data for scientific study and profit but was not willing to guarantee the resulting advantages from any future treatments.

"We will now turn to the difficult and regrettable process of winding down our health assistance in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont publicly.

Her embassy noted the United States had donated over $1.9bn for health programmes to Zimbabwe over the last twenty years.

A doctors' association in Zimbabwe has urged continued dialogue to find a agreement acceptable to both sides so the nation's vital HIV programme can be sustained.

Broader Implications

Zimbabwe's decision comes after a similar case in Kenya, where a high court halted a similar deal with the US after legal challenges were raised about the security of Kenyans' health data.

Since returning to the presidency last year, US President Donald Trump has reduced overseas assistance and shut down the US Agency for International Development (USAID).

The agency had administered aid for the US government, but Trump stated its expenditure was "inefficient" and his government was pursuing direct bilateral deals to boost transparency and responsibility.

According to statements, 16 African countries have so far signed these new health pacts, constituting over $18.3bn in committed funds.

Details of the Rejected Deal

This assistance for Zimbabwe was intended to supported "combating HIV/Aids, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness.

"We are confident this partnership could have provided significant benefits for the people of Zimbabwe, especially the 1.2 million men, women and children currently receiving antiretroviral therapy via American-funded initiatives," the Ambassador said.

However, government spokesperson Nick Mangwana said the proposed deal was "unequal".

"The proposal required Zimbabwe to share its biological resources and data for a long time, with no equivalent guarantee of access to any scientific breakthroughs – like new medicines or tests – that might result from that provided information," his statement read.

"In essence, our country would provide the raw materials for medical research without any assurance that the end products would be available to our population if a new health crisis emerge."

Sovereignty and International Frameworks

Mangwana further pointed out that the US's withdrawal from the global health body and its pursuit of one-on-one health agreements were upending frameworks already set up through the global organization.

The spokesperson gave as an example its Pathogen Access and Benefit Sharing system created to deal with potential global health emergencies.

"This mechanism is designed to guarantee that when a nation provides its data, the resulting advantages – including vaccines and treatments – are distributed fairly, not commercialised exclusively by those with the funds to develop them."

The government's concerns over the US deal "must not be interpreted as anti-American sentiment," he added.

"We encourage ongoing dialogue with our US partners on how subsequent collaboration could be structured in a way that honours the independence and interests of both nations."

Health Experts Reaction

Medical experts stated it recognised the government's concerns, but urged that negotiations need to persist since much of the nation's HIV programmes relied on international support.

"In cases where technical issues arise, such as those involving information security or implementation frameworks, these can frequently be resolved through detailed discussion and mutually agreed protections," it added.

This impasse highlights the complex debate between accepting much-needed foreign assistance and safeguarding local interests in an increasingly data-driven world.

DW
By

Donna Weaver

A tech journalist and digital strategist with over a decade of experience covering emerging technologies and cybersecurity trends.

SolidPortal UK

Type to search articles.